Ekström-Smedby Karin
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Acta Oncol. 2006;45(3):258-71. doi: 10.1080/02841860500531682.
The etiology of non-Hodgkin lymphoma, as well as its global dramatic rise in incidence during the past decades, remains largely unexplained. However, there is increasing awareness that this group of malignancies may entail not only clinical, morphological and molecular heterogeneity, but also considerable variations in terms of etiologic factors. In this review, epidemiologic patterns are summarized as well as current evidence of associations between various known or suspected risk factors for non-Hodgkin lymphoma overall or for any of its subtypes. Central pathogenetic mechanisms include immunosuppression, especially in relation to T-cell function and loss of control of latent EBV infection, and chronic antigen stimulation. Some degree of familiar aggregation also implies a role for genetic susceptibility. A number of recent investigations of non-Hodgkin lymphoma etiology will hopefully lead to a better understanding of the causes of these malignancies.
非霍奇金淋巴瘤的病因,以及在过去几十年里其全球发病率急剧上升的情况,在很大程度上仍未得到解释。然而,人们越来越意识到,这组恶性肿瘤不仅可能在临床、形态学和分子水平上存在异质性,而且在病因方面也存在相当大的差异。在这篇综述中,总结了流行病学模式以及各种已知或疑似非霍奇金淋巴瘤总体或其任何亚型的危险因素之间关联的当前证据。主要的发病机制包括免疫抑制,特别是与T细胞功能以及潜伏性EB病毒感染控制丧失相关的免疫抑制,以及慢性抗原刺激。一定程度的家族聚集也暗示了遗传易感性的作用。最近对非霍奇金淋巴瘤病因的一些研究有望使人们更好地了解这些恶性肿瘤的病因。